Million investment for lung cancer therapy
Belgian biotech start-up will use funding to start first-in-human clinical study for lead drug candidate in lung cancer
23-Jan-2023 -
DeuterOncology, a clinical-stage drug development company, announces the closing of its €5.65 million ($6.1M) Series A financing, with participation from historical investor Newton Biocapital and new investors Noshaq and Investsud Tech. This funding will enable the company to start the phase I ...
cancer
cancer drugs
lung cancer
+1